CCRM
Manuel Alvarez is an Associate Director at CCRM, with experience dating back to April 2012. In this role, Manuel has served as a research technician and lab manager, where responsibilities included maintaining cell cultures, running analytical tests for cell quality, and managing lab supplies and inventory systems. Prior to CCRM, Manuel worked as a Research Technician at the University of Toronto from March 2006 to March 2012, where maintenance of human embryonic stem cell cultures and support for scientists were key duties. Manuel holds a Master’s degree in Pathology/Experimental Pathology from Western University and a Bachelor of Science in Biology from the University of Windsor.
This person is not in any teams
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.